Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

It’s a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (or ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut ...

Some risk factors for epithelial ovarian cancer are modifiable, according to a study published online Jan. 6 in the ...

Women who’ve ever used the contraceptive pill have a 26% lower risk of ovarian cancer, researchers say. Women who used the ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

While ovarian cancer is usually believed to be a silent killer, being aware of the warning signs and risk factors can save ...

Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to redirect cells toward the tumor. | Immunology ...